From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia
The haematological malignancies are a heterogeneous group of neoplastic disorders, which lead to almost 10,000 deaths annually in the UK. Over the past 2 decades, there has been significant progress in our understanding of the pathological mechanisms underlying these cancers, accompanied by improvem...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Published: |
Royal College of Physicians
2018
|